Synthesis and evaluation of novel potent HCV NS5A inhibitors (Q39330313)

11 September 2017

Synthesis and evaluation of novel potent HCV NS5A inhibitors (English)

1 reference

11 September 2017

11

Raymond F Schinazi

1 reference

11 September 2017

7

Tamara R McBrayer

1 reference

11 September 2017

6

Sijia Tao

1 reference

11 September 2017

1

Hongwang Zhang

1 reference

11 September 2017

8

Phillip M Tharnish

1 reference

11 September 2017

3

Franck Amblard

1 reference

11 September 2017

2

Longhu Zhou

1 reference

11 September 2017

4

Junxing Shi

1 reference

11 September 2017

Drew R Bobeck

5

1 reference

11 September 2017

Tony Whitaker

series ordinal

9

1 reference

11 September 2017

Steven J Coats

series ordinal

10

1 reference

11 September 2017

language of work or name

English

0 references

publication date

24 May 2012

1 reference

Bioorganic & Medicinal Chemistry Letters

11 September 2017

5

1 reference

based on heuristic

inferred from page(s)

published in

1 reference

11 September 2017

22

1 reference

11 September 2017

14

1 reference

11 September 2017

4864-4868

1 reference

Advances in nucleoside monophosphate prodrugs as anti-HCV agents

11 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3389222

Resistance analysis of the hepatitis C virus NS5A inhibitor BMS-790052 in an in vitro replicon system

11 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3389222

Chemical genetics strategy identifies an HCV NS5A inhibitor with a potent clinical effect

11 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3389222

Copper-catalyzed azide-alkyne cycloaddition (CuAAC) and beyond: new reactivity of copper(I) acetylides

11 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3389222

HCV drug discovery aimed at viral eradication

11 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3389222

Identification of Hepatitis C Virus NS5A Inhibitors

11 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3389222

Cu(I)-catalyzed Huisgen azide-alkyne 1,3-dipolar cycloaddition reaction in nucleoside, nucleotide, and oligonucleotide chemistry

11 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3389222

Ser(2194) is a highly conserved major phosphorylation site of the hepatitis C virus nonstructural protein NS5A.

11 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3389222

New Merck and Vertex drugs raise standard of care in hepatitis C

25 September 2017

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22704887

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Mono- and disalicylic acid derivatives: PTP1B inhibitors as potential anti-obesity drugs

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22704887

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1016/J.BMCL.2012.05.039

1 reference

11 September 2017

1 reference

11 September 2017

PubMed publication ID

22704887

1 reference